RC
NVO

Rexford Capital’s Novo Nordisk NVO Stock Holding History

Rexford Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$95.6K Buy
2,602
+166
+7% +$7.87K 0.07% 210
2025
Q4 		$124K Sell
2,436
-400
-14% -$20.5K 0.09% 206
2025
Q3 		$157K Buy
2,836
+950
+50% +$55.6K 0.12% 191
2025
Q2 		$130K Buy
+1,886
New +$128K 0.11% 198

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Rexford Capital's NVO Position: Q1 2026 in Review

Rexford Capital increased its Novo Nordisk (NVO) stake by 6.8% in Q1 2026, buying an estimated $7.87K and bringing the position to 2,602 shares worth $95.6K. The position accounts for 0.07% of the portfolio, ranked #210.

Rexford Capital first reported a position in NVO in Q2 2025 and has held it in 4 quarters since. The position peaked at $157K in Q3 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Rexford Capital held 2,602 shares of Novo Nordisk worth $95.6K as of Q1 2026.
  • Rexford Capital bought 166 Novo Nordisk shares in Q1 2026, an estimated $7.87K.
  • Novo Nordisk made up 0.07% of Rexford Capital's portfolio in Q1 2026, its #210 holding.
  • Rexford Capital first reported a position in Novo Nordisk in Q2 2025 and has held it in 4 quarters since.
  • Rexford Capital's Novo Nordisk position peaked at $157K in Q3 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Rexford Capital's 13F filing for Q1 2026, filed 24 Apr 2026.